CDH13 and hepatocellular carcinoma: Similar to the expression pattern of T-cadherin in other tumors, T-cadherin was underexpressed in hepatocellular carcinoma cells (26.5%, 13/49 cases) but was frequently (77.6%, 38/49 cases) overexpressed in tumor endothelial cells (77).